The reincarnation of a shuttered Los Angeles retail mecca as a sprawling UCLA research center has received a major boost from billionaire philanthropist Dr. Gary Michelson and his…
Read more Major gift accelerates transformation of old mall into UCLA research hubHope is on the horizon for millions of Alzheimer’s disease patients as scientists develop a new target for Alzheimer’s treatment: the immune system. Alzheimer’s affects roughly 5.8 million…
Read more Alzheimer’s disease “game changer” as progression slowed with immunotherapyDoctors once thought non-small-cell lung cancer (NSCLC) was one disease. Most people got the same treatment — chemotherapy (chemo) — especially if their cancer had spread to other…
Read more NSCLC: Advances in TreatmentNSCLC: Advances in Treatment …
Read more NSCLC: Advances in TreatmentNSCLC: When You Need More Than One Treatment …
Read more NSCLC: When You Need More Than One TreatmentStandard chemotherapy (chemo) was once the only treatment for advanced non-small-cell lung cancer (NSCLC). Now, you’re likely to get chemo plus a targeted medicine or immunotherapy, says Karen…
Read more NSCLC: When You Need More Than One TreatmentBy Alison Massey, as told to Susan Bernstein There is a perception that chemotherapy is like treatments from 20 or 30 years ago. They think it will have…
Read more Treating Inoperable Lung Cancer: A Nurse’s PerspectiveBy David Tom Cooke, MD, as told to Susan Bernstein The term is “inoperable lung cancer.” It means that the risk of surgery to remove the lung cancer…
Read more Inoperable Lung Cancer: Innovations That Are Changing the Outlook
